Adaptive Biotechnologies
ADPT
ADPT
226 hedge funds and large institutions have $1.18B invested in Adaptive Biotechnologies in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 85 increasing their positions, 63 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 223 → 226 (+3)
0.54% more ownership
Funds ownership: 92.84% → 93.39% (+0.54%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
226
Holding in Top 10
2
Calls
$2.73M
Puts
$364K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$10.3M | |
| 3 | +$8.17M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$5.73M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.55M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$8.13M | |
| 3 | -$6.13M | |
| 4 |
BlackRock
New York
|
-$5.35M |
| 5 |
SIG
Senator Investment Group
New York
|
-$4.42M |